$HIMS News
Last published 1d ago
- 1d agoLLYHIMSNVDANasdaq Jumps Over 4% This Week as Chip Names Drive a Sharp Midweek RallyPR NewswireStock Preachers News Commentary - Stocks staged a broad midweek advance, with the Nasdaq Composite climbing 2.06% on the session and 4.08% for...
- 1d agoTDOCAMWLDOCSHIMSA $400 Billion Healthcare Opportunity: Telehealth Companies Positioned to Capitalize on a Massive Industry ShiftGlobeNewswireHealthcare Innovation and Technology Adoption Are Reshaping How Millions of Patients Access Medical Services
- 3d agoHIMSHims & Hers Third Quarter 2026 Earnings Call - HIMS & HERS HEALTH INCEarnings Call TranscriptsHello, everyone. Thank you for joining us and welcome to the Hims and Hers Health 3rd Quarter 2026 Earnings Call. After today's prepared remarks, we will host a question and answer session. If you would like to ask a que
- 3d agoHIMSHims & Hers Health, Inc. - EX-99.1Earnings ReleasesForm 8-K - Current report - Item 2.02 Item 8.01 Item 9.01
- 3d agoHIMSHims & Hers Health, Inc. Reports Third Quarter 2026 Financial ResultsBusiness WireSAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (“Hims & Hers” or the “Company”, NYSE: HIMS), the leading global health and wellness platform, today announced financial results for the third quarter ended September 30, 2026. “In healthcare, whoever owns the customer relationship wins, and that’s exactly what we’re building toward at Hims & Hers. Today, customers want real choice, real val ...
- 3d agoHIMSDr. Andrew Huberman Joins Hims & Hers Board of DirectorsBusiness WireSAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading global health and wellness platform, announced the appointment of Andrew Huberman, Ph.D., to the company’s Board of Directors. Dr. Huberman is a world-renowned neuroscientist and tenured professor in the Departments of Neurobiology and Ophthalmology at Stanford University School of Medicine. He has au ...
- 3d agoAMGNLLYHIMSIndices Hunt for Support After Steep Weekly Losses as Volatility Gauge Stays ElevatedPR NewswireStock Preachers News Commentary - Wall Street opens a new week nursing bruises from a rough stretch that sent every major index lower, with the...
- 6d agoLLYHIMSLilly and Hims & Hers expand access to FDA-approved Lilly medicinesPR NewswireEli Lilly and Company (NYSE: LLY) and Hims & Hers Health, Inc. (NYSE: HIMS) today announced an agreement to help expand access to Zepbound...
- 1w agoPNGAFMBXKLRAALT+1Federal Peptide Policy Shift Could Ignite a New Wave Of Growth Across the $164 Billion Peptide MarketGlobeNewswireNEW YORK, Nov. 05, 2026 (GLOBE NEWSWIRE) -- The federal government's October 30, 2026, decision could be a big deal for the peptide industry. HHS has signaled that it does not intend to pursue enforcement action
- 2w agoPNGAFNVOHIMSENHA+1The $294 Billion Peptide Boom: Biotech Companies Positioned for the Next Wave of GrowthGlobeNewswireNEW YORK, Oct. 29, 2026 (GLOBE NEWSWIRE) -- Peptide-based medicines are becoming a bigger force in the pharmaceutical industry, and the money flowing into this field reflects that shift. Obesity and diabetes
- 3w agoHIMSHims Expands Testosterone Care with Injectable and Oral TRT, Its Largest Men’s Health Launch to DateBusiness WireNew injectable and oral options offer eligible men more ways to get proactive about their testosterone health Hims & Hers Health, Inc. (NYSE:HIMS), the leading global health and wellness platform, today announced
- 4w agoHIMSShareholders who lost money in shares of acquired Hims & Hers Health, Inc. (NYSE: HIMS) should contact Wolf Haldenstein ImmediatelyPR NewswireLead Plaintiff Deadline November 2, 2026NEW YORK, Oct. 14, 2026 /PRNewswire/ -- Wolf Haldenstein Adler Freeman & Herz LLP ("Wolf Haldenstein"), a nationally recognized securities litigation law firm,
- 1mo agoHIMSHims & Hers to Announce Third Quarter 2026 Financial Results on November 9, 2026Business WireHims & Hers Health, Inc. (("Hims &, Hers", NYSE:HIMS), the leading global health and wellness platform, today announced that it will report third quarter 2026 financial results after the market closes
- 1mo agoHIMSHers Launches in Australia, Built to Care for the Whole WomanBusiness WireJuniper becomes Hers, bringing new treatments spanning hair regrowth, menopause and perimenopause, and comprehensive weight management Hims & Hers, the leading global health and wellness platform, today announced
- 1mo agoHIMSHims & Hers Names Jon Franklin as Chief Accounting OfficerBusiness WireCertified Public Accountant and former Rivian corporate controller will lead Hims & Hers accounting organization as the company expands into new specialties and global markets Hims & Hers Health, Inc.
- 1mo agoHIMSHims & Hers Names Chief Medical Officers in the UK and Australia, Deepening its Investment in Local Clinical LeadershipBusiness WireKultar Garcha, MD, joins as Chief Medical Officer of the UK and EMEA, and Matt Vickers, FRACGP, MBBS, BMedSci, AICGG, is named Chief Medical Officer of Hims Australia, guiding clinical strategy as Hims & Hers
- 2mo agoHIMSHims Arrives in Australia, Bringing Personalised Care for Men NationwideBusiness WirePilot becomes Hims, bringing innovative, personalised care to help Australian men manage sexual health, weight loss, and hair loss Hims & Hers, the leading global health and wellness platform, today announced it
- 2mo agoHIMSHims Enters Australia, Marking First Expansion into the Asia-Pacific MarketBusiness WireWith the rebrand of Pilot, Eucalyptus' men's health platform, Hims enters a new market, supporting its path to $1 billion in international annual revenue within the next three years Hims & Hers Health,
- 2mo agoHIMSHims & Hers CEO says FTC lawsuit misunderstands how the company worksCNBCHims & Hers CEO Andrew Dudum spoke to CNBC about the FTC's lawsuit against the company, compounded GLP-1 drugs and AI.
- 2mo agoICEHIMSRDDTSNOWUniphore Launches Marketing AI to Usher in New Era: NYSE Content UpdatePR NewswireNYSE issues a pre-market daily advisory direct from the trading floor.NEW YORK, Aug. 17, 2026 /CNW/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access
- 3mo agoHIMSHims & Hers Health, Inc. Reports Second Quarter 2026 Financial ResultsBusiness WireRevenue of approximately $753 million, up 38% year-over-year in Q2 2026 Subscribers grew to nearly 2.9 million, up 19% year-over-year in Q2 2026 Raises full year 2026 revenue guidance to a range of $3.1 billion to
- 3mo agoHIMSLowey Dannenberg, P.C. is Investigating Hims & Hers Health, Inc. (NYSE: HIMS) for Potential Violations of the Federal Securities LawsGlobeNewswireNEW YORK, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, is investigating Hims & Hers Health, Inc. (NYSE:HIMS) ("Hims &
- 3mo agoHIMSHims & Hers Introduces New Hers App with First-of-Its-Kind, Doctor-Led, AI-Native Care ExperienceBusiness WireRebuilt from the ground up, the new Hers app puts women in one continuous conversation with their providers, Care Teams, and AI, delivering personalized weight loss support the moment she needs it Hims & Hers,
- 3mo agoHIMSMETASNAPMSFT+4FTC sues Hims & Hers for allegedly sharing patients’ medical data with advertisers Meta and SnapTechCrunch
- 3mo ago.DJIUS30YHIMSYUM+6Warsh's inflation problem, Meta's weak guidance, Chipotle earnings and more in Morning SquawkCNBCHere are five key things investors need to know to start the trading day.
- 3mo agoHIMSMETASNAPHims and Hers shares fall 10% as FTC sues company over data, billing practicesCNBCThe FTC sued Hims & Hers over alleged health data sharing with Meta and Snap, billing practices and subscription cancellations.
- 3mo agoHIMSHims & Hers Responds to FTC LawsuitBusiness WireHims & Hers Health, Inc. (NYSE:HIMS) responded to the lawsuit filed today by the Federal Trade Commission (FTC): This lawsuit disregards substantial evidence we provided the FTC during its nearly three-year
- 3mo agoHIMSHims & Hers Chief Accounting Officer, Irene Becklund, Announces Departure from the CompanyBusiness WireHims & Hers Health, Inc. (NYSE:HIMS), the leading health and wellness platform, today announced its Chief Accounting Officer, Irene Becklund will depart the company after more than seven years, effective October 9,
- 4mo agoHIMSHims & Hers to Announce Second Quarter 2026 Financial Results on August 10, 2026Business WireHims & Hers Health, Inc. (("Hims &, Hers", NYSE:HIMS), the leading health and wellness platform, today announced that it will report second quarter 2026 financial results after the market closes on
- 5mo agoHIMSHims & Hers Names Dr. Anant Vinjamoori as Chief Medical Officer of HimsBusiness WireAn expert in longevity medicine and preventive healthcare, Vinjamoori joins Hims & Hers to help more men feel great at every stage of life Hims & Hers Health, Inc. (NYSE:HIMS), the leading health and wellness
- 5mo agoHIMSHims & Hers Completes Acquisition of Eucalyptus, Advancing its Position as the World's Largest Consumer Health PlatformBusiness WireThe acquisition extends the company's leadership position across Australia, Canada, Germany, Japan, and the United Kingdom, with the scale to redefine healthcare for hundreds of millions of people Hims & Hers
- 5mo agoHIMSHims & Hers Completes Acquisition of Eucalyptus, Accelerating Its Push to Transform Healthcare for CanadiansBusiness WireBuilding on its Canadian launch and the historic introduction of generic semaglutide, Hims & Hers brings the full power of the world's largest consumer health platform — and Juniper's proven track record —
- 5mo agoHIMSHims & Hers Completes Acquisition of Eucalyptus, Parent Company of Juniper, Officially Entering Japanese MarketBusiness WireClosing brings the scale, technology and clinical infrastructure of Hims & Hers to Japan Hims & Hers Health, Inc. has completed its acquisition of Eucalyptus, the parent company of Juniper, marking a
- 5mo agoHIMSHims & Hers Completes Acquisition of Eucalyptus, Expanding Access to Comprehensive, Clinically-Backed Weight Management Care in GermanyBusiness WireClosing brings world-class technology and clinical infrastructure to a market where Juniper has helped patients achieve clinically meaningful weight loss Hims & Hers Health, Inc. has completed its acquisition of
- 5mo agoHIMSHims & Hers Completes Acquisition of Eucalyptus, Advancing Position as the World's Largest Consumer Health PlatformBusiness WireEntering Australia for the first time, Hims & Hers will combine scale, technology, and clinical expertise to make personalised, whole-body care more accessible to every Australian Hims & Hers Health, Inc. has
- 5mo agoHIMSHims & Hers Expands Benefits for Active Subscribers With Eight New Health and Wellness PartnersBusiness WireFrom connected fitness and cycle tracking to meal delivery and glucose monitoring, Hims & Hers subscribers now have ten ways to support their whole-body health Hims & Hers Health, Inc. (NYSE:HIMS), the leading
- 5mo agoDJTHIMSLLYMMA+2Peptide-Based Health Industry Positioned for Explosive Long-Term Growth Across Global Wellness MarketsGlobeNewswireNEW YORK, May 21, 2026 (GLOBE NEWSWIRE) -- Market News Updates News Commentary - The market for peptide-based health and performance products has been growing fast as more consumers focus on fitness, recovery, longevity, weight management, and overall wellness.
- 5mo agoHIMSHims & Hers Expands GLP-1 Offering in Canada with Generic SemaglutideBusiness WireBy introducing access to generic semaglutide in Canada, the company is meeting the needs of a dynamic market and continuing its international expansion efforts Hims & Hers Health, Inc. (NYSE:HIMS), the leading
- 5mo agoHIMSHims & Hers Brings First-Time Access to Generic Semaglutide to CanadaBusiness WirePersonalised treatment plans pair medication with unlimited Care Team support, nutrition and lifestyle guidance, and Canadian medical expertise, starting at $149/month Hims & Hers Health, Inc. (NYSE:HIMS), the
- 5mo agoHIMSHims & Hers Health, Inc. Prices Upsized $350 Million Convertible Senior Notes Offering to Support International Expansion and Accelerate AI-Driven Platform InvestmentBusiness WireProceeds intended to be used to preserve financial flexibility as Hims & Hers executes on its international expansion strategy, including the proposed acquisition of Eucalyptus, invests in technology and operational
- 5mo agoHIMSHims & Hers Health, Inc. Announces Proposed Convertible Senior Notes Offering to Support International Expansion and Accelerate AI-Driven Platform InvestmentBusiness WireProceeds intended to be used to preserve financial flexibility as Hims & Hers executes on its international expansion strategy, including the proposed acquisition of Eucalyptus, invests in technology and operational
- 6mo agoHIMSNVOMNKDDNAThe $59B Quiet Shift Reshaping How Patients Access CarePR NewswirePoint-of-care diagnostics just crossed $58.76 billion globally in 2026, growing at nearly 10% annually as testing that used to require a hospital lab ...
- 6mo agoHIMSLLYNVOPFE+1Peptide Wellness Market Could Near $300 Billion as Consumer Demand AcceleratesGlobeNewswireNEW YORK, May 12, 2026 (GLOBE NEWSWIRE) -- Market News Updates News Commentary -- Investor interest in the next-generation wellness market is picking up fast as peptide-based health and performance products become more
- 6mo agoHIMSHims & Hers First Quarter 2026 Earnings CallHIMS & HERS HEALTH INCEarnings Call TranscriptsHello, and thank you for standing by. My name is Tiffany, and I will be your conference operator today. At this time, I would like to welcome everyone to the HIMSS and HERSS First Quarter 2026 Earnings Call. All lines ha
- 6mo agoHIMSHims & Hers Health, Inc. Reports First Quarter 2026 Financial ResultsBusiness WireRevenue of approximately $608 million, up 4% year-over-year in Q1 2026 Subscribers grew to nearly 2.6 million, up 9% year-over-year in Q1 2026 Raises full year 2026 revenue guidance1 to a range of $2.8 billion to
- 6mo agoHIMSHims & Hers Nominates Kofi Amoo-Gottfried to its Board of DirectorsBusiness WireIf elected, the marketing leader from transformative companies like DoorDash and Meta will join a diverse board with medical, tech, and consumer expertise Hims & Hers Health, Inc. (("Hims &, Hers", NYSE:HIMS),
- 6mo agoHIMSDrizzle on top: a new high-end dog food brand is coming for the 1%TechCrunch
- 6mo ago.DJI.SPXBAUAL+6Ceasefire extension, Best Buy's new CEO, Amazon's GLP-1 push and more in Morning SquawkCNBCHere are five key things investors need to know to start the trading day.
- 6mo agoHIMSAMGNVKTXSEPN+3Amazon launches GLP-1 weight loss program, promising 'fast, convenient' accessCNBCThrough Amazon Pharmacy, patients will be able to access medications including Novo Nordisk's Wegovy as well as newer oral GLP-1 options.
- 6mo ago.SPX.IXICNFLXWBD+10The Nasdaq's win streak, Netflix earnings, another AI pivot and more in Morning SquawkCNBCHere are five key things investors need to know to start the trading day.